Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

Nicolò Matteo Luca Battisti,Victoria True,Narda Chaabouni,Neha Chopra,Karla Lee,Scott Shepherd,Tal Shapira-Rotenberg,Rashi Joshi,Sophie E. McGrath,Alicia Okines,M. Parton,Nicholas C. Turner,Kabir Mohammed,M Allen,Stephen R. D. Johnston,Alistair Ring

Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

2019

Nicolò Matteo Luca Battisti
Victoria True
Narda Chaabouni
Neha Chopra
Karla Lee
Scott Shepherd
Tal Shapira-Rotenberg
Rashi Joshi
Sophie E. McGrath
Alicia Okines
M. Parton
Nicholas C. Turner
Kabir Mohammed
M Allen
Stephen R. D. Johnston
Alistair Ring

Purpose Pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) for breast cancer predicts the risk of recurrence and increasingly may indicate the need for additional therapy postoperatively.

Keywords:

Cancer research
Pathological
Neoadjuvant therapy
Oncology
Additional Therapy
Internal medicine
Systemic therapy
Medicine
Breast cancer
Chemotherapy
Trastuzumab
Pertuzumab
Estrogen receptor
Disease
Histopathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations